Long and Post-Acute COVID-19
COVID-19 is a novel disease which is revealing unprecedented challenges. While many patients with symptoms fortunately can survive acute disease, a substantial cohort undergoes a sustained clinical picture, exhibiting a subacute stage or “long” COVID-19. While the etiology of subacute COVID-19 remains unclear, disturbed immune responses, viral persistence, neural cell damage may be possible mechanisms. Further a multidisciplinary approach is needed to treat those patients.
Luiz Eugênio Mello
Scientific Director, FAPESP
Heart Institute, University of São Paulo School of Medicine
(INCOR/FMUSP) and FAPESP
Regis Goulard Rosa
Moinho dos Ventos Hospital, Porto Alegre
Division of Pulmonary and Critical Care Medicine, Oregon Health & Science University
Medical School, University of São Paulo (FMUSP)
School of Medicine,Yale University
There will be no certificate/declaration of presence
for events broadcast on YouTube YouTube.
You can participate in a Q & A panel. Please, send your comments
and questions (in English or Portuguese) to email@example.com.